The Anson Group
11460 N. Meridian Street, Suite 150
Carmel, Indiana 46032
Ph (317) 569-9500
Fax (317) 569-9520
TF (866) 521-9500
info@ansongroup.com
 |
The Anson Group11460 N. Meridian Street, Suite 150 |
|
The Anson Group is an independent consulting organization that provides services and strategies for FDA product approval and compliance for devices, drugs, biologics and combination products, with primary emphasis on facilitating technology commercialization.
Our team of pharmaceutical experts provides regulatory and development task outsourcing alternatives for drug and biotech clients of all sizes, as well as comprehensive project planning and management services that help them to meet their business objectives and enhance the value of their technologies.
Gerald Richardson
Managing Partner
grichardson@ansongroup.com
Colleen Hittle, RAC
Managing Partner
chittle@ansongroup.com
O. Reed Tarwater, Ph.D., RAC
Director of Pharmaceutical Services
rtarwater@ansongroup.com
The Anson Group has experience to provide consulting for a wide variety of regulatory activities across the continuum of drug development, from preclinical testing to post marketing activities, including:
The Anson Group has experience with a variety of regulatory mechanisms to enhance drug development and will advise clients, when appropriate, on the possibility of seeking such methods including Orphan Drug designation, Fast Track designation, Accelerated Approval and Priority Review.